We should be proud that BTA is at world stage in medicine and helping(obviously making money too) to mankind.
Problem is: Competition is getting fears from Asian Giants too(Cipla India, UK, Swedish Company). Another six months few more will flood the market with Anti Flu. It is business and where there is opportunity, companies invest in that directions.
Until unless BTA either buys all competitors or keep improving Relenza, their piece of Slice will keep getting smaller and smaller. Also with time Royality decreses as price drops.
BTA Price at posting:
$1.50 Sentiment: Hold Disclosure: Held
